The DOI matches its Crossref record.
Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”
Abstract
Cushing's syndrome is due to chronic glucocorticoid excess that may have various etiologies. The most common endogenous form is pituitary-dependent bilateral adrenal hyperplasia, which is termed Cushing's disease. Major depression occurs in more than half of the cases. The presence of depressive symptoms connotes severity of clinical presentation and, in patients with hypothalamic-pituitary forms, entails prognostic value. Medical treatment may be used while awaiting more definitive solutions for the illness by surgery. The inhibitors of steroid production (e.g., ketoconazole, metyrapone and aminoglutethimide), rather than antidepressant drugs, are generally successful in lifting depression as well as other disabling symptoms. Since central serotonergic regulation could have a role in the course of Cushing's disease, serotonin antagonists (e.g., cyproheptadine, ritanserin and ketanserin) have been employed. Findings related to the pharmacological response of depression in Cushing's disease were found to have implications for the pathophysiology of depression and the potential involvement of the hypothalamic-pituitary-adrenal axis (HPA axis) in resistance and tolerance to antidepressant drugs. The use of serotonergic drugs in Cushing's disease may yield important insights in the understanding of serotonergic regulation both in Cushing's disease and in the HPA axis in nonendocrine major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is extensive evidence to suggest that the hypothalamic-pituitary-adrenal axis (HPA) could modulate sensitization and/or tolerance to antidepressants by its reciprocal interactions with serotonin neuroreceptors [49].”
Citations
Cites
Still being checked.
Cited by
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Self-citationPsychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. A. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 108
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 66
Self-citationTreatment of Recurrent Depression: A Sequential Psychotherapeutic and Psychopharmacological Approach
Fava, G. A., Ruini, C., & Sonino, N. (2003) · CNS Drugs · doi:10.2165/00023210-200317150-00005 · Cited by 69
Self-citation
Metadata
- Authors
- Sonino, N., & Fava, G. A.
- Affiliations
- University of Padua (IT)
- University of Bologna (IT)
- ORCID
- Fava, Giovanni A.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 26
- Issue
- 5
- Pages
- 1011-1018
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W1992270145
- Cited by
- 11
- References
- 0
- Citations by year
- 2022: 1 · 2018: 1 · 2015: 1 · 2014: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero dell'Università e della Ricerca
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's disease, major depressive disorder, mood disorders, glucocorticoid excess, hypothalamic-pituitary-adrenal axis, antidepressant resistance, serotonergic drugs, cyproheptadine, ketoconazole, metyrapone, aminoglutethimide, steroidogenesis inhibitors, depression pathophysiology
- MeSH terms
- Central Nervous System Agents, Cushing Syndrome, Humans, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”. https://app.cochat.ai/papers/10.1016/s0278-5846(02)00252-x
- The paper
- Sonino, N., & Fava, G. A. (2002). Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/s0278-5846(02)00252-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.